CAV1 and melanoma: To further evaluate this possibility, we focused on two metastatic cell models lacking E-cadherin, B16F10 murine melanoma cells that lack CAV1 expression and MDA-MB-231 human breast cancer cells with high endogenous levels of CAV1.